M 725 (Benazepril hydrochloride and hydrochlorothiazide 5 mg / 6.25 mg)
Pill imprint M 725 has been identified as Benazepril hydrochloride and hydrochlorothiazide 5 mg / 6.25 mg.
Benazepril/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Benazepril/hydrochlorothiazide 5 mg / 6.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M 725
- 5 mg / 6.25 mg
- 10.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- ACE inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
ferric oxide yellow
More about benazepril/hydrochlorothiazide
- Hydrochlorothiazide and benazepril
- Benazepril and hydrochlorothiazide (Advanced Reading)
- Other brands: Lotensin HCT
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.